Trial Profile
A double-blind, randomised, placebo- and active-controlled trial evaluating the effects of multiple-dose fasiglifam on cardiac repolarisation in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Fasiglifam (Primary) ; Moxifloxacin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 09 Nov 2015 New trial record